Key facts
- Notable investors include Gather Ventures, Product & Prosper.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for GNGR Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for GNGR Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GNGR Labs
Producer of immunity-boosting health drinks intended to support recovery from fatigue and burnout caused by chronic stress. The company offers ginger shots and probiotic drinks that help with digestion, and immunity, and act as anti-inflammatory support, enabling consumers to overcome low immune health conditions.
- Sector
- Consumer Products and Services (B2C)
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 7
- Website
- gngrlabs.com/
- Ownership
- Privately Held (backing)
GNGR Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GNGR Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GNGR Labs in its N-PORT filings yet. We sweep new filings monthly.